January 4 According to a report quoted by the European Union News Agency by the European Network, the Italian Ministry of Civil Defense announced 14,245 new confirmed cases of the novel coronavirus and 347 deaths on the 3rd. As of 18:00 on the 3rd, there were 2,155,446 confirmed cases, 75,332 deaths and 1,503,900 cured cases in Italy.
It is reported that the Sicilian Regional Health Bureau reported on the 3rd that a female doctor tested positive for the novel coronavirus six days after being vaccinated against the novel coronavirus at Umberto I Hospital in Syracuse, Sicily.
According to the source, the female doctor diagnosed after vaccination against the novel coronavirus is the first group of medical staff vaccinated in the local health system. The doctor was hospitalized for observation and treatment on January 2.
Brussferro, president of the Italian National Institute of Health, explained about the infection after vaccination, that research shows that the Pfizer-BioNTech coronavirus vaccine currently being clinically applied in Italy will only truly achieve immune protection after a second dose of vaccine and for a certain period of time.
Brussifero said that in the third clinical trial of Pfizer-BioNTech, there were also people infected with their immune system without protecting their immune system after receiving the first dose of the vaccine. Vaccine production units have made it clear that immune protection will only form after the second dose of vaccine forms antibodies.
Brusaferro appealed to the public not to relax their vigilance against epidemic prevention until they have formed immunity after the first dose of COVID-19 vaccine and the second dose of vaccine, but still strictly abide by the epidemic prevention rules, maintain the necessary safe social distance and wear masks.
Acuri, director of Italy’s National Coronavirus Emergency Response Committee, also said that Italy’s coverage of coronavirus vaccines is far behind that of the United Kingdom, Germany and Croatia. In order to accelerate vaccination in the future, the shortage of medical staff and syringes must be addressed.
